title: ACP Journal Club. In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone.
authors.affiliation: Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Amy T
authors.initials: AT
authors.lastname: Wang
authors.forename: Steven A
authors.initials: SA
authors.lastname: Smith